REGISTER HERE

True innovation often appears before its time. At first, it may seem intangible, almost invisible — an idea awaiting the right moment to be fully understood.

Our X50 technology, cell targeted delivery system followed that very path. Today, science has caught up with our vision with X50 NeoSyno-Col®.

Guided by expertise, creativity, and bold design, our team has developed a unique pairing of collagen-boosting peptides, precisely vectorized to their cellular target. The result is outstanding anti-wrinkle and dermal regeneration efficacy at exceptionally low dosages — an innovation made for the next generation of high-performance skin care.

With the support of advanced in vivo penetration studies, innovative cell co-culture and receptor-binding techniques, and high-resolution imaging of internalization, X50 NeoSyno-Col® now reveals with clarity what our foresight anticipated from the very beginning: a delivery system that navigates, identifies its target, and releases cosmetic actives exactly where they are needed most.

Precision cosmetics redefined. Welcome to the new era of targeted skin care.

Speakers

Dr. Christian Bellacanzone is the Global Head of Applied Innovation in Delivery Systems at Evonik, specializing in nanotechnology and biology. With advanced degrees in Molecular, Industrial Biotechnology and Material Science, he has led significant research and development initiatives in both academic and industrial settings.

Mr. Juan Gonzalez is the Global Head of Marketing in Delivery Systems at Evonik, specializing in nanotechnology and biology. With degrees in International Marketing and Economics, he has worked for more than two decades in the field of cosmetic active ingredients, mass market, FMCG (fast-moving consumer goods) and dermocosmetics.

REGISTER HERE

Approval to attend this webinar is at the discretion of Evonik